CpG oligodeoxynucleotides with hepatitis B surface antigen (HBsAg) for vaccination in HBsAg-transgenic mice. - Wikidata - awgldk - TriplyDB

CpG oligodeoxynucleotides with hepatitis B surface antigen (HBsAg) for vaccination in HBsAg-transgenic mice.

CpG oligodeoxynucleotides with hepatitis B surface antigen (HBsAg) for vaccination in HBsAg-transgenic mice.

http://www.wikidata.org/entity/Q33843264

about

Current and future antiviral drug therapies of hepatitis B chronic infection Use of immunostimulatory sequence-containing oligonucleotides as topical therapy for genital herpes simplex virus type 2 infection.Effective postexposure treatment of retrovirus-induced disease with immunostimulatory DNA containing CpG motifs Immunization with hepatitis C virus-like particles induces humoral and cellular immune responses in nonhuman primates.Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity.Bacteriophage lambda display systems: developments and applications.Treatment options beyond IFNα and NUCs for chronic HBV infection: expectations for tomorrow.Plasmid vector-linked maturation of natural killer (NK) cells is coupled to antigen-dependent NK cell activation during DNA-based immunization in mice Atopy in children with chronic hepatitis B virus infection.A CpG oligodeoxynucleotide enhances the immune response to rabies vaccination in mice

P2860

Q28084820-9121FE43-2306-4D93-A052-B1E7EFA7F40B Q34354995-240F0EA1-425F-4840-BC9C-C4B0B51A4B1F Q34355633-F093F11B-8BD6-439E-A40F-E7571601B7D8 Q34437852-467964B1-B24B-4098-AFF0-7875ACA8C6B4 Q36990647-05EA697A-BFA6-45C8-8E31-CEE20C22A1BC Q38179995-EC071404-7FF1-4EDB-B779-EE400AB91BF2 Q38255840-CBA519AA-E8C2-4345-97FF-3479FACF28A2 Q38749284-2E13C8D9-3C9E-4B3E-8FF2-27828F7806EE Q45401427-41A0467F-F561-4FC9-98CF-77E84F5255F3 Q59127186-B886BE1D-81A7-4086-8EC0-1D29D1FD16F7

P2860

CpG oligodeoxynucleotides with hepatitis B surface antigen (HBsAg) for vaccination in HBsAg-transgenic mice.

http://www.wikidata.org/entity/Q33843264

description

2001 nî lūn-bûn

@nan

2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

CpG oligodeoxynucleotides with ...... tion in HBsAg-transgenic mice.

@ast

CpG oligodeoxynucleotides with ...... tion in HBsAg-transgenic mice.

@en

type

label

CpG oligodeoxynucleotides with ...... tion in HBsAg-transgenic mice.

@ast

CpG oligodeoxynucleotides with ...... tion in HBsAg-transgenic mice.

@en

prefLabel

CpG oligodeoxynucleotides with ...... tion in HBsAg-transgenic mice.

@ast

CpG oligodeoxynucleotides with ...... tion in HBsAg-transgenic mice.

@en

P1433

Q33843264-6FABDB98-8FE4-467F-805C-FAA921BEFB3B

P1476

Q33843264-D0A0A575-4EE8-40FA-B16E-3567BD6B0F47

P2093

Q33843264-18F38164-1299-4CD5-9ECB-DCDFFB431143

Q33843264-6E41B02C-7A46-48EF-B849-3AA3837E2B5F

Q33843264-78D9CC67-E6C1-420E-9EB9-85A14B68F8DF

Q33843264-83A39432-3CF9-4007-B18F-EF9D2E6FDB75

Q33843264-D30BE14C-3D4A-4CEC-87DF-842A48426949

P2860

Q33843264-0CD35578-82B3-48CF-8860-2A040A48EA67

Q33843264-0E03839A-08A7-41E8-B669-76992C37B286

Q33843264-169949AA-F484-4BF8-8163-F3B41327033C

Q33843264-16B63945-BE25-4963-B2B7-E4F18182E217

Q33843264-1771144A-F6C0-42B4-A332-CA1002DF9DE0

Q33843264-1853A6AB-4A23-4BE1-8B48-BC65FDAB3774

Q33843264-28064825-B390-4054-83EC-7AD1FFDB9026

Q33843264-30318F42-74E5-4D53-871E-24252BE41EEA

Q33843264-34291786-E260-4EB8-B2C4-D4F24A775BD8

Q33843264-403443C1-945D-45E3-A89A-E81D65305EDC

P304

Q33843264-B4A7E4DB-A0A8-4F5D-97B5-096A32102F9C

P31

Q33843264-79E1A6E3-92F4-4E28-9567-9C82E4A84625

P356

Q33843264-B523C654-61D7-4BB1-B1DA-C6ABED3744E5

P433

Q33843264-E31DAFC6-FB18-4768-9604-5C2ED6540DB6

P478

Q33843264-6170CDB2-C56D-4275-9EC4-FE5CDBBE0E35

P50

Q33843264-6852007F-A66D-435E-A1D3-DE1B1039C7E2

P577

Q33843264-AF359C9F-0322-41E1-B294-078B14E9EE83

P698

Q33843264-6226F22A-9836-4969-B731-25A14610A538

P932

Q33843264-DF225DDE-9872-40FB-9217-C77E35F7A0CE

P356

JVI.75.14.6482-6491.2001

P1433

Journal of Virology

P1476

CpG oligodeoxynucleotides with ...... tion in HBsAg-transgenic mice.

@en

P2093

E Malanchère-Brès

http://www.w3.org/2001/XMLSchema#string

H L Davis

http://www.w3.org/2001/XMLSchema#string

M L Michel

http://www.w3.org/2001/XMLSchema#string

M Mancini

http://www.w3.org/2001/XMLSchema#string

P J Payette

http://www.w3.org/2001/XMLSchema#string

P2860

CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma

DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier state

Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization

Response of naïve and memory CD8+ T cells to antigen stimulation in vivo.

Immune effects and mechanisms of action of CpG motifs.

Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans.

DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans.

CpG motifs in bacterial DNA trigger direct B-cell activation.

IFN-gamma promotes IL-6 and IgM secretion in response to CpG motifs in bacterial DNA and oligodeoxynucleotides.

Immunostimulatory DNA sequences necessary for effective intradermal gene immunization.

P304

6482-6491

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.75.14.6482-6491.2001

http://www.w3.org/2001/XMLSchema#string

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

75

http://www.w3.org/2001/XMLSchema#string

P50

Pierre Tiollais

P577

2001-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11413315

http://www.w3.org/2001/XMLSchema#string

P932

114371

http://www.w3.org/2001/XMLSchema#string